Histopathological and pharmacological studies on the action of a new anti-inflammatory agent (BR 700).
The effect of a new anti-inflammatory agent, 2-phenyl-4-p-chlorophenyl-thiazol-5-ylacetic acid (BR 700) on the development of cover slip granuloma was studied. The drug decreased macrophage emigration and delayed some characteristic processes of the mononuclear cells.